Key result
Frailty defined by FRAIL and SPPB independently predicted waitlist mortality in kidney transplant candidates.
Why the study?
Frailty predicts adverse outcomes in kidney transplant candidates, but whether different frailty tools identify the same or distinct at-risk patients remains unclear.
Do the FRAIL scale and SPPB capture distinct risk phenotypes in kidney transplant candidates?
Cohort (n=953)
Do the FRAIL scale and SPPB capture distinct risk phenotypes in kidney transplant candidates?
The FRAIL scale and SPPB capture distinct dimensions of frailty in kidney transplant candidates, supporting the systematic use of both instruments for optimal risk stratification.
Answers are grounded in this paper and cite their sources.
Different frailty tools may identify distinct at-risk kidney transplant candidates; leaves open which better predicts outcomes or informs interventions.
Frailty predicts adverse outcomes in kidney transplant candidates, but it remains unclear whether different frailty tools identify the same or distinct at-risk patients. In this retrospective cohort study, 953 kidney transplant candidates listed between 2018 and 2022 underwent frailty assessment using both the FRAIL (Fatigue, Resistance, Ambulation, Illnesses, Weight Loss) scale and Short Physical Performance Battery (SPPB). In a subset with available CT imaging, body composition was analyzed using AI-based tools. Frailty prevalence differed by instrument: 6.2% by FRAIL versus 24% by SPPB. Waitlist mortality occurred in 9.5% (91/953) of candidates. Both tools independently predicted waitlist mortality (FRAIL:aHR 2.38, 95%CI 1.34-4.20,p=0.003; SPPB:aHR 1.66, 95%CI 1.07-2.60,p=0.025). SPPB-defined frailty showed stronger associations with post-transplant outcomes, including longer hospital stay, and 30-day and one-year readmissions. CT analysis revealed that SPPB-defined, but not FRAIL-defined, frailty was associated with lower muscle density and increased visceral adiposity, suggesting a mechanistic basis. The FRAIL scale and SPPB capture distinct dimensions of frailty with complementary strengths. FRAIL better reflects symptom burden and candidates at risk for waitlist mortality, while SPPB more closely associates with post-transplant complications. Results support systematic use of both instruments to optimize risk stratification and identify candidates who may benefit from targeted prehabilitation.
No takes yet. Share an insight, caveat, or question.
Verhoeff et al. (2026) conducted a cohort in Kidney transplant candidates (n=953). Frailty (assessed by FRAIL scale and SPPB) vs. Non-frail candidates was evaluated on Waitlist mortality (aHR 2.38, 95% CI 1.34-4.20, p=0.003). Frailty defined by FRAIL and SPPB independently predicted waitlist mortality in kidney transplant candidates.
Synapse has enriched 10 related papers. Consider them for comparative context: